A new type of cancer-killing molecule, not previously described
All medical research, especially cancer research, has two simultaneous visions: The first is to make new and unexpected discoveries that creates new knowledge about conditions regarding life and health. The second is to reveal how diseases arise, what interrupts normal body functions and how cancer can cause the extensive damages that affect seriously ill patients.
The two visions within cancer research coincides in HAMLET
The two visions coincides in Hamlet. The discovery of HAMLET identified a new type of cancer-killing molecule, which has not previously been described. Many properties of HAMLET are unexpected and challenging: the protein´s changed structure and the presence of a oleic acid, the broad effect against many kinds of tumor cells and the high degree of selectivity for tumor cells. At the same time these properties make HAMLET to a new drug candidate, that so far has shown high efficacy in clinical studies and animal models. HAMLET has so far shown no side effects and the substance could be produced with a relatively simple production method.
HAMLET can therefore be the type of drug that is needed to better treat cancer patients. Despite the progress in cancer care, the need for new drugs remains very large and biologicals with cancer-killing effects start to become increasingly common.